?>
Logo

MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 401k Plan overview

Plan NameMOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN
Plan identification number 001

MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
  • Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

MOLECULAR EPIDEMIOLOGY, INC. has sponsored the creation of one or more 401k plans.

Company Name:MOLECULAR EPIDEMIOLOGY, INC.
Employer identification number (EIN):911759869
NAIC Classification:541990
NAIC Description:All Other Professional, Scientific, and Technical Services

Additional information about MOLECULAR EPIDEMIOLOGY, INC.

Jurisdiction of Incorporation: Washington Secretary of State Corporations Division
Incorporation Date: 1997-02-21
Company Identification Number: 601771019
Legal Registered Office Address: 15300 BOTHELL WY NE

LAKE FOREST PARK
United States of America (USA)
981550000

More information about MOLECULAR EPIDEMIOLOGY, INC.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012022-01-01
0012021-01-01
0012020-01-01
0012019-01-01
0012018-01-01
0012017-01-01DALIA ALFI
0012016-01-01DALIA ALFI
0012015-01-01DALIA ALFI
0012014-01-01DALIA ALFI
0012013-01-01DALIA ALFI
0012012-01-01DALIA ALFI
0012011-01-01DALIA ALFI
0012009-01-01 DALIA ALFI2010-10-12
0012008-01-01DALIA ALFI

Plan Statistics for MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN

401k plan membership statisitcs for MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN

Measure Date Value
2022: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year2022-01-011,307
Total number of active participants reported on line 7a of the Form 55002022-01-011,233
Number of retired or separated participants receiving benefits2022-01-017
Number of other retired or separated participants entitled to future benefits2022-01-01221
Total of all active and inactive participants2022-01-011,461
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2022-01-010
Total participants2022-01-011,461
Number of participants with account balances2022-01-01835
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2022-01-0110
2021: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year2021-01-011,225
Total number of active participants reported on line 7a of the Form 55002021-01-011,153
Number of retired or separated participants receiving benefits2021-01-013
Number of other retired or separated participants entitled to future benefits2021-01-01151
Total of all active and inactive participants2021-01-011,307
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2021-01-010
Total participants2021-01-011,307
Number of participants with account balances2021-01-01609
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2021-01-011
2020: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year2020-01-011,216
Total number of active participants reported on line 7a of the Form 55002020-01-011,075
Number of retired or separated participants receiving benefits2020-01-016
Number of other retired or separated participants entitled to future benefits2020-01-01144
Total of all active and inactive participants2020-01-011,225
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2020-01-010
Total participants2020-01-011,225
Number of participants with account balances2020-01-01544
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2020-01-012
2019: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year2019-01-011,118
Total number of active participants reported on line 7a of the Form 55002019-01-011,122
Number of retired or separated participants receiving benefits2019-01-0193
Total of all active and inactive participants2019-01-011,215
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2019-01-011
Total participants2019-01-011,216
Number of participants with account balances2019-01-01514
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2019-01-013
2018: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year2018-01-01736
Total number of active participants reported on line 7a of the Form 55002018-01-011,063
Number of retired or separated participants receiving benefits2018-01-0155
Total of all active and inactive participants2018-01-011,118
Total participants2018-01-011,118
Number of participants with account balances2018-01-01354
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2018-01-012
2017: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year2017-01-01898
Total number of active participants reported on line 7a of the Form 55002017-01-01691
Number of retired or separated participants receiving benefits2017-01-015
Number of other retired or separated participants entitled to future benefits2017-01-0140
Total of all active and inactive participants2017-01-01736
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2017-01-010
Total participants2017-01-01736
Number of participants with account balances2017-01-01300
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2017-01-013
2016: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year2016-01-01771
Total number of active participants reported on line 7a of the Form 55002016-01-01824
Number of retired or separated participants receiving benefits2016-01-013
Number of other retired or separated participants entitled to future benefits2016-01-0135
Total of all active and inactive participants2016-01-01862
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2016-01-010
Total participants2016-01-01862
Number of participants with account balances2016-01-01246
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2016-01-012
2015: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2015 401k membership
Total participants, beginning-of-year2015-01-01674
Total number of active participants reported on line 7a of the Form 55002015-01-01724
Number of retired or separated participants receiving benefits2015-01-012
Number of other retired or separated participants entitled to future benefits2015-01-0145
Total of all active and inactive participants2015-01-01771
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2015-01-010
Total participants2015-01-01771
Number of participants with account balances2015-01-01226
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2015-01-011
2014: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2014 401k membership
Total participants, beginning-of-year2014-01-01682
Total number of active participants reported on line 7a of the Form 55002014-01-01627
Number of retired or separated participants receiving benefits2014-01-010
Number of other retired or separated participants entitled to future benefits2014-01-0147
Total of all active and inactive participants2014-01-01674
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2014-01-010
Total participants2014-01-01674
Number of participants with account balances2014-01-01228
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2014-01-0111
2013: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2013 401k membership
Total participants, beginning-of-year2013-01-01611
Total number of active participants reported on line 7a of the Form 55002013-01-01615
Number of retired or separated participants receiving benefits2013-01-010
Number of other retired or separated participants entitled to future benefits2013-01-0167
Total of all active and inactive participants2013-01-01682
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2013-01-010
Total participants2013-01-01682
Number of participants with account balances2013-01-01236
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2013-01-016
2012: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2012 401k membership
Total participants, beginning-of-year2012-01-01570
Total number of active participants reported on line 7a of the Form 55002012-01-01582
Number of retired or separated participants receiving benefits2012-01-010
Number of other retired or separated participants entitled to future benefits2012-01-0129
Total of all active and inactive participants2012-01-01611
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2012-01-010
Total participants2012-01-01611
Number of participants with account balances2012-01-01250
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2012-01-0125
2011: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2011 401k membership
Total participants, beginning-of-year2011-01-01440
Total number of active participants reported on line 7a of the Form 55002011-01-01486
Number of retired or separated participants receiving benefits2011-01-010
Number of other retired or separated participants entitled to future benefits2011-01-0184
Total of all active and inactive participants2011-01-01570
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2011-01-010
Total participants2011-01-01570
Number of participants with account balances2011-01-01249
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2011-01-015
2009: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year2009-01-01163
Total number of active participants reported on line 7a of the Form 55002009-01-01150
Number of retired or separated participants receiving benefits2009-01-010
Number of other retired or separated participants entitled to future benefits2009-01-0142
Total of all active and inactive participants2009-01-01192
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2009-01-010
Total participants2009-01-01192
Number of participants with account balances2009-01-01117
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2009-01-010
2008: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2008 401k membership
Total participants, beginning-of-year2008-01-01159
Total number of active participants reported on line 7a of the Form 55002008-01-01127
Number of retired or separated participants receiving benefits2008-01-010
Number of other retired or separated participants entitled to future benefits2008-01-0136
Total of all active and inactive participants2008-01-01163
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2008-01-010
Total participants2008-01-01163
Number of participants with account balances2008-01-01120
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2008-01-015

Financial Data on MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN

Measure Date Value
2022 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2022 401k financial data
Total transfer of assets to this plan2022-12-31$3,211,507
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$60,822
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$27,947
Total income from all sources (including contributions)2022-12-31$-772,088
Total of all expenses incurred2022-12-31$3,510,890
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-12-31$3,330,803
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-12-31$2,977,522
Value of total assets at end of year2022-12-31$21,631,766
Value of total assets at beginning of year2022-12-31$22,670,362
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-12-31$180,087
Total interest from all sources2022-12-31$25,851
Total dividends received (eg from common stock, registered investment company shares)2022-12-31$1,088,442
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2022-12-31$1,088,442
Was this plan covered by a fidelity bond2022-12-31Yes
Value of fidelity bond cover2022-12-31$500,000
If this is an individual account plan, was there a blackout period2022-12-31No
Were there any nonexempt tranactions with any party-in-interest2022-12-31No
Contributions received from participants2022-12-31$2,561,319
Participant contributions at end of year2022-12-31$356,388
Participant contributions at beginning of year2022-12-31$259,572
Participant contributions at end of year2022-12-31$7,445
Participant contributions at beginning of year2022-12-31$1,074
Income. Received or receivable in cash from other sources (including rollovers)2022-12-31$22,896
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2022-12-31$60,822
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2022-12-31$27,947
Other income not declared elsewhere2022-12-31$48,129
Administrative expenses (other) incurred2022-12-31$180,087
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Value of net income/loss2022-12-31$-4,282,978
Value of net assets at end of year (total assets less liabilities)2022-12-31$21,570,944
Value of net assets at beginning of year (total assets less liabilities)2022-12-31$22,642,415
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2022-12-31No
Were any leases to which the plan was party in default or uncollectible2022-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-12-31$19,555,460
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-12-31$20,971,328
Interest on participant loans2022-12-31$12,348
Interest earned on other investments2022-12-31$13,503
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2022-12-31$1,709,880
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2022-12-31$1,438,388
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-12-31$-4,912,032
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-12-31No
Was there a failure to transmit to the plan any participant contributions2022-12-31Yes
Has the plan failed to provide any benefit when due under the plan2022-12-31No
Contributions received in cash from employer2022-12-31$393,307
Employer contributions (assets) at end of year2022-12-31$2,593
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-12-31$3,330,803
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32022-12-31No
Did the plan have assets held for investment2022-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-12-31No
Opinion of an independent qualified public accountant for this plan2022-12-31Unqualified
Accountancy firm name2022-12-31VISSE & COMPANY
Accountancy firm EIN2022-12-31542088418
2021 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2021 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$27,947
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$49,119
Total income from all sources (including contributions)2021-12-31$5,554,251
Total of all expenses incurred2021-12-31$1,687,271
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$1,536,801
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$2,749,155
Value of total assets at end of year2021-12-31$22,670,362
Value of total assets at beginning of year2021-12-31$18,824,554
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$150,470
Total interest from all sources2021-12-31$20,734
Total dividends received (eg from common stock, registered investment company shares)2021-12-31$1,026,177
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2021-12-31$1,026,177
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$500,000
If this is an individual account plan, was there a blackout period2021-12-31No
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$2,028,673
Participant contributions at end of year2021-12-31$259,572
Participant contributions at beginning of year2021-12-31$259,561
Participant contributions at end of year2021-12-31$1,074
Participant contributions at beginning of year2021-12-31$238
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$718,454
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2021-12-31$27,947
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2021-12-31$49,119
Other income not declared elsewhere2021-12-31$36,182
Administrative expenses (other) incurred2021-12-31$150,470
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Value of net income/loss2021-12-31$3,866,980
Value of net assets at end of year (total assets less liabilities)2021-12-31$22,642,415
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$18,775,435
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$20,971,328
Value of interest in pooled separate accounts at beginning of year2021-12-31$17,238,871
Interest on participant loans2021-12-31$10,736
Interest earned on other investments2021-12-31$9,998
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2021-12-31$1,438,388
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2021-12-31$1,325,884
Net investment gain/loss from registered investment companies (e.g. mutual funds)2021-12-31$325,088
Net investment gain/loss from pooled separate accounts2021-12-31$1,396,915
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31Yes
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Contributions received in cash from employer2021-12-31$2,028
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$1,536,801
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32021-12-31No
Did the plan have assets held for investment2021-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31No
Opinion of an independent qualified public accountant for this plan2021-12-31Unqualified
Accountancy firm name2021-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2021-12-31542088418
2020 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2020 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$49,119
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$8,373
Total income from all sources (including contributions)2020-12-31$4,215,811
Total of all expenses incurred2020-12-31$970,198
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2020-12-31$904,261
Expenses. Certain deemed distributions of participant loans2020-12-31$0
Value of total corrective distributions2020-12-31$49,119
Total contributions o plan (from employers,participants, others, non cash contrinutions)2020-12-31$1,916,377
Value of total assets at end of year2020-12-31$18,824,554
Value of total assets at beginning of year2020-12-31$15,538,195
Total of administrative expenses incurred including professional, contract, advisory and management fees2020-12-31$16,818
Total interest from all sources2020-12-31$15,135
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2020-12-31No
Was this plan covered by a fidelity bond2020-12-31Yes
Value of fidelity bond cover2020-12-31$500,000
If this is an individual account plan, was there a blackout period2020-12-31No
Were there any nonexempt tranactions with any party-in-interest2020-12-31No
Contributions received from participants2020-12-31$1,797,558
Participant contributions at end of year2020-12-31$259,561
Participant contributions at beginning of year2020-12-31$168,395
Participant contributions at end of year2020-12-31$238
Participant contributions at beginning of year2020-12-31$1,856
Income. Received or receivable in cash from other sources (including rollovers)2020-12-31$2,466
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2020-12-31$49,119
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2020-12-31$8,373
Other income not declared elsewhere2020-12-31$11,236
Administrative expenses (other) incurred2020-12-31$8,845
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Value of net income/loss2020-12-31$3,245,613
Value of net assets at end of year (total assets less liabilities)2020-12-31$18,775,435
Value of net assets at beginning of year (total assets less liabilities)2020-12-31$15,529,822
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2020-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2020-12-31No
Were any leases to which the plan was party in default or uncollectible2020-12-31No
Value of interest in pooled separate accounts at end of year2020-12-31$17,238,871
Value of interest in pooled separate accounts at beginning of year2020-12-31$13,889,005
Interest on participant loans2020-12-31$9,282
Interest earned on other investments2020-12-31$5,853
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2020-12-31$1,325,884
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2020-12-31$1,478,939
Net investment gain/loss from registered investment companies (e.g. mutual funds)2020-12-31$2,273,063
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2020-12-31No
Was there a failure to transmit to the plan any participant contributions2020-12-31Yes
Has the plan failed to provide any benefit when due under the plan2020-12-31No
Contributions received in cash from employer2020-12-31$116,353
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2020-12-31$904,261
Contract administrator fees2020-12-31$7,973
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32020-12-31No
Did the plan have assets held for investment2020-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2020-12-31No
Opinion of an independent qualified public accountant for this plan2020-12-31Disclaimer
Accountancy firm name2020-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2020-12-31542088418
2019 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2019 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$8,373
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$32,226
Total income from all sources (including contributions)2019-12-31$4,248,228
Total of all expenses incurred2019-12-31$671,319
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$642,231
Expenses. Certain deemed distributions of participant loans2019-12-31$6,838
Value of total corrective distributions2019-12-31$7,619
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$1,712,766
Value of total assets at end of year2019-12-31$15,538,195
Value of total assets at beginning of year2019-12-31$11,985,139
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$14,631
Total interest from all sources2019-12-31$9,071
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$500,000
If this is an individual account plan, was there a blackout period2019-12-31No
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$1,487,202
Participant contributions at end of year2019-12-31$168,395
Participant contributions at beginning of year2019-12-31$158,755
Participant contributions at end of year2019-12-31$1,856
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$95,186
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2019-12-31$8,373
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2019-12-31$32,226
Other income not declared elsewhere2019-12-31$45,285
Administrative expenses (other) incurred2019-12-31$12,111
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$3,576,909
Value of net assets at end of year (total assets less liabilities)2019-12-31$15,529,822
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$11,952,913
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Investment advisory and management fees2019-12-31$2,520
Value of interest in pooled separate accounts at end of year2019-12-31$13,889,005
Value of interest in pooled separate accounts at beginning of year2019-12-31$10,532,053
Interest on participant loans2019-12-31$9,071
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2019-12-31$1,478,939
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2019-12-31$1,294,331
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$2,481,106
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31Yes
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$130,378
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$642,231
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2019-12-31542088418
2018 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2018 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$32,226
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$19,323
Total income from all sources (including contributions)2018-12-31$718,545
Total of all expenses incurred2018-12-31$675,548
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2018-12-31$630,626
Value of total corrective distributions2018-12-31$32,226
Total contributions o plan (from employers,participants, others, non cash contrinutions)2018-12-31$1,454,042
Value of total assets at end of year2018-12-31$11,985,139
Value of total assets at beginning of year2018-12-31$11,929,239
Total of administrative expenses incurred including professional, contract, advisory and management fees2018-12-31$12,696
Total interest from all sources2018-12-31$17,031
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2018-12-31No
Was this plan covered by a fidelity bond2018-12-31Yes
Value of fidelity bond cover2018-12-31$500,000
If this is an individual account plan, was there a blackout period2018-12-31No
Were there any nonexempt tranactions with any party-in-interest2018-12-31No
Contributions received from participants2018-12-31$1,222,971
Participant contributions at end of year2018-12-31$158,755
Participant contributions at beginning of year2018-12-31$200,626
Income. Received or receivable in cash from other sources (including rollovers)2018-12-31$108,914
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2018-12-31$32,226
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2018-12-31$19,323
Administrative expenses (other) incurred2018-12-31$10,600
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Value of net income/loss2018-12-31$42,997
Value of net assets at end of year (total assets less liabilities)2018-12-31$11,952,913
Value of net assets at beginning of year (total assets less liabilities)2018-12-31$11,909,916
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2018-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2018-12-31No
Were any leases to which the plan was party in default or uncollectible2018-12-31No
Investment advisory and management fees2018-12-31$2,096
Value of interest in pooled separate accounts at end of year2018-12-31$10,532,053
Value of interest in pooled separate accounts at beginning of year2018-12-31$10,497,449
Interest on participant loans2018-12-31$8,270
Interest earned on other investments2018-12-31$8,761
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2018-12-31$1,294,331
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2018-12-31$1,231,164
Net investment gain/loss from registered investment companies (e.g. mutual funds)2018-12-31$-752,528
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2018-12-31No
Was there a failure to transmit to the plan any participant contributions2018-12-31No
Has the plan failed to provide any benefit when due under the plan2018-12-31No
Contributions received in cash from employer2018-12-31$122,157
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2018-12-31$630,626
Did the plan have assets held for investment2018-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2018-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2018-12-31Yes
Opinion of an independent qualified public accountant for this plan2018-12-31Disclaimer
Accountancy firm name2018-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2018-12-31542088418
2017 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2017 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$19,323
Total income from all sources (including contributions)2017-12-31$2,694,406
Total of all expenses incurred2017-12-31$665,114
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2017-12-31$608,184
Expenses. Certain deemed distributions of participant loans2017-12-31$0
Value of total corrective distributions2017-12-31$19,323
Total contributions o plan (from employers,participants, others, non cash contrinutions)2017-12-31$1,173,568
Value of total assets at end of year2017-12-31$11,929,239
Value of total assets at beginning of year2017-12-31$9,880,624
Total of administrative expenses incurred including professional, contract, advisory and management fees2017-12-31$37,607
Total interest from all sources2017-12-31$16,095
Total dividends received (eg from common stock, registered investment company shares)2017-12-31$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2017-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2017-12-31$0
Was this plan covered by a fidelity bond2017-12-31Yes
Value of fidelity bond cover2017-12-31$500,000
If this is an individual account plan, was there a blackout period2017-12-31No
Were there any nonexempt tranactions with any party-in-interest2017-12-31No
Contributions received from participants2017-12-31$946,158
Participant contributions at end of year2017-12-31$200,626
Participant contributions at beginning of year2017-12-31$142,818
Participant contributions at end of year2017-12-31$0
Participant contributions at beginning of year2017-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2017-12-31$106,512
Value of other receiveables (less allowance for doubtful accounts) at end of year2017-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2017-12-31$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2017-12-31$19,323
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Value of net income/loss2017-12-31$2,029,292
Value of net assets at end of year (total assets less liabilities)2017-12-31$11,909,916
Value of net assets at beginning of year (total assets less liabilities)2017-12-31$9,880,624
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2017-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2017-12-31No
Were any leases to which the plan was party in default or uncollectible2017-12-31No
Investment advisory and management fees2017-12-31$32,216
Value of interest in pooled separate accounts at end of year2017-12-31$10,497,449
Value of interest in pooled separate accounts at beginning of year2017-12-31$8,596,541
Interest on participant loans2017-12-31$7,965
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2017-12-31$8,130
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2017-12-31$1,231,164
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2017-12-31$1,141,265
Expenses. Payments to insurance carriers foe the provision of benefits2017-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2017-12-31$1,504,743
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2017-12-31No
Was there a failure to transmit to the plan any participant contributions2017-12-31No
Has the plan failed to provide any benefit when due under the plan2017-12-31No
Contributions received in cash from employer2017-12-31$120,898
Employer contributions (assets) at end of year2017-12-31$0
Employer contributions (assets) at beginning of year2017-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2017-12-31$608,184
Contract administrator fees2017-12-31$5,391
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32017-12-31No
Did the plan have assets held for investment2017-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2017-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2017-12-31Yes
Opinion of an independent qualified public accountant for this plan2017-12-31Disclaimer
Accountancy firm name2017-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2017-12-31542088418
2016 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2016 401k financial data
Total income from all sources (including contributions)2016-12-31$1,556,411
Total of all expenses incurred2016-12-31$272,757
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2016-12-31$214,074
Expenses. Certain deemed distributions of participant loans2016-12-31$0
Value of total corrective distributions2016-12-31$26,374
Total contributions o plan (from employers,participants, others, non cash contrinutions)2016-12-31$875,982
Value of total assets at end of year2016-12-31$9,880,624
Value of total assets at beginning of year2016-12-31$8,596,970
Total of administrative expenses incurred including professional, contract, advisory and management fees2016-12-31$32,309
Total interest from all sources2016-12-31$14,067
Total dividends received (eg from common stock, registered investment company shares)2016-12-31$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2016-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2016-12-31$0
Was this plan covered by a fidelity bond2016-12-31Yes
Value of fidelity bond cover2016-12-31$500,000
If this is an individual account plan, was there a blackout period2016-12-31No
Were there any nonexempt tranactions with any party-in-interest2016-12-31No
Contributions received from participants2016-12-31$770,507
Participant contributions at end of year2016-12-31$142,818
Participant contributions at beginning of year2016-12-31$164,714
Participant contributions at end of year2016-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2016-12-31$1,986
Value of other receiveables (less allowance for doubtful accounts) at end of year2016-12-31$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Value of net income/loss2016-12-31$1,283,654
Value of net assets at end of year (total assets less liabilities)2016-12-31$9,880,624
Value of net assets at beginning of year (total assets less liabilities)2016-12-31$8,596,970
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2016-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2016-12-31No
Were any leases to which the plan was party in default or uncollectible2016-12-31No
Investment advisory and management fees2016-12-31$26,889
Value of interest in pooled separate accounts at end of year2016-12-31$8,596,541
Value of interest in pooled separate accounts at beginning of year2016-12-31$7,536,192
Interest on participant loans2016-12-31$6,610
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2016-12-31$7,457
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2016-12-31$1,141,265
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2016-12-31$896,064
Expenses. Payments to insurance carriers foe the provision of benefits2016-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2016-12-31$666,362
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2016-12-31No
Was there a failure to transmit to the plan any participant contributions2016-12-31No
Has the plan failed to provide any benefit when due under the plan2016-12-31No
Contributions received in cash from employer2016-12-31$103,489
Employer contributions (assets) at end of year2016-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2016-12-31$214,074
Contract administrator fees2016-12-31$5,420
Did the plan have assets held for investment2016-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2016-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2016-12-31Yes
Opinion of an independent qualified public accountant for this plan2016-12-31Disclaimer
Accountancy firm name2016-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2016-12-31542088418
2015 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2015 401k financial data
Total income from all sources (including contributions)2015-12-31$857,357
Total of all expenses incurred2015-12-31$521,417
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2015-12-31$437,910
Value of total corrective distributions2015-12-31$54,481
Total contributions o plan (from employers,participants, others, non cash contrinutions)2015-12-31$960,867
Value of total assets at end of year2015-12-31$8,596,970
Value of total assets at beginning of year2015-12-31$8,261,030
Total of administrative expenses incurred including professional, contract, advisory and management fees2015-12-31$29,026
Total interest from all sources2015-12-31$13,103
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2015-12-31No
Was this plan covered by a fidelity bond2015-12-31Yes
Value of fidelity bond cover2015-12-31$500,000
If this is an individual account plan, was there a blackout period2015-12-31No
Were there any nonexempt tranactions with any party-in-interest2015-12-31No
Contributions received from participants2015-12-31$693,643
Participant contributions at end of year2015-12-31$164,714
Participant contributions at beginning of year2015-12-31$161,805
Income. Received or receivable in cash from other sources (including rollovers)2015-12-31$181,652
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Value of net income/loss2015-12-31$335,940
Value of net assets at end of year (total assets less liabilities)2015-12-31$8,596,970
Value of net assets at beginning of year (total assets less liabilities)2015-12-31$8,261,030
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2015-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2015-12-31No
Were any leases to which the plan was party in default or uncollectible2015-12-31No
Investment advisory and management fees2015-12-31$24,939
Value of interest in pooled separate accounts at end of year2015-12-31$7,536,192
Value of interest in pooled separate accounts at beginning of year2015-12-31$7,262,511
Interest on participant loans2015-12-31$6,682
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2015-12-31$6,421
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2015-12-31$896,064
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2015-12-31$836,714
Net gain/loss from 103.12 investment entities2015-12-31$-116,613
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2015-12-31No
Was there a failure to transmit to the plan any participant contributions2015-12-31No
Has the plan failed to provide any benefit when due under the plan2015-12-31No
Contributions received in cash from employer2015-12-31$85,572
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2015-12-31$437,910
Contract administrator fees2015-12-31$4,087
Did the plan have assets held for investment2015-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2015-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2015-12-31Yes
Opinion of an independent qualified public accountant for this plan2015-12-31Disclaimer
Accountancy firm name2015-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2015-12-31542088418
2014 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2014 401k financial data
Total income from all sources (including contributions)2014-12-31$1,747,467
Total of all expenses incurred2014-12-31$719,378
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2014-12-31$693,261
Expenses. Certain deemed distributions of participant loans2014-12-31$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)2014-12-31$1,358,977
Value of total assets at end of year2014-12-31$8,261,030
Value of total assets at beginning of year2014-12-31$7,232,941
Total of administrative expenses incurred including professional, contract, advisory and management fees2014-12-31$26,117
Total interest from all sources2014-12-31$13,147
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2014-12-31No
Was this plan covered by a fidelity bond2014-12-31Yes
Value of fidelity bond cover2014-12-31$500,000
If this is an individual account plan, was there a blackout period2014-12-31No
Were there any nonexempt tranactions with any party-in-interest2014-12-31No
Contributions received from participants2014-12-31$665,618
Participant contributions at end of year2014-12-31$161,805
Participant contributions at beginning of year2014-12-31$165,156
Income. Received or receivable in cash from other sources (including rollovers)2014-12-31$616,149
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Value of net income/loss2014-12-31$1,028,089
Value of net assets at end of year (total assets less liabilities)2014-12-31$8,261,030
Value of net assets at beginning of year (total assets less liabilities)2014-12-31$7,232,941
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2014-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2014-12-31No
Were any leases to which the plan was party in default or uncollectible2014-12-31No
Investment advisory and management fees2014-12-31$22,416
Value of interest in pooled separate accounts at end of year2014-12-31$7,262,511
Value of interest in pooled separate accounts at beginning of year2014-12-31$6,300,246
Interest on participant loans2014-12-31$6,786
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2014-12-31$6,361
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2014-12-31$836,714
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2014-12-31$767,539
Net investment gain/loss from pooled separate accounts2014-12-31$375,343
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2014-12-31No
Was there a failure to transmit to the plan any participant contributions2014-12-31No
Has the plan failed to provide any benefit when due under the plan2014-12-31No
Contributions received in cash from employer2014-12-31$77,210
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2014-12-31$693,261
Contract administrator fees2014-12-31$3,701
Did the plan have assets held for investment2014-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2014-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2014-12-31Yes
Opinion of an independent qualified public accountant for this plan2014-12-31Disclaimer
Accountancy firm name2014-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2014-12-31542088418
2013 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2013 401k financial data
Total income from all sources (including contributions)2013-12-31$1,646,570
Total of all expenses incurred2013-12-31$482,749
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$450,297
Value of total corrective distributions2013-12-31$13,431
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$671,056
Value of total assets at end of year2013-12-31$7,232,941
Value of total assets at beginning of year2013-12-31$6,069,120
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$19,021
Total interest from all sources2013-12-31$13,148
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$500,000
If this is an individual account plan, was there a blackout period2013-12-31No
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$603,849
Participant contributions at end of year2013-12-31$165,156
Participant contributions at beginning of year2013-12-31$163,857
Participant contributions at beginning of year2013-12-31$1,815
Income. Received or receivable in cash from other sources (including rollovers)2013-12-31$930
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$1,163,821
Value of net assets at end of year (total assets less liabilities)2013-12-31$7,232,941
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$6,069,120
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Investment advisory and management fees2013-12-31$19,021
Value of interest in pooled separate accounts at end of year2013-12-31$6,300,246
Value of interest in pooled separate accounts at beginning of year2013-12-31$5,034,294
Interest on participant loans2013-12-31$7,062
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2013-12-31$6,086
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2013-12-31$767,539
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2013-12-31$869,154
Net investment gain/loss from pooled separate accounts2013-12-31$962,366
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31No
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Contributions received in cash from employer2013-12-31$66,277
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$450,297
Did the plan have assets held for investment2013-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2013-12-31Yes
Opinion of an independent qualified public accountant for this plan2013-12-31Disclaimer
Accountancy firm name2013-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2013-12-31542088418
2012 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2012 401k financial data
Total transfer of assets to this plan2012-12-31$815,341
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$9,529
Total income from all sources (including contributions)2012-12-31$1,257,804
Total of all expenses incurred2012-12-31$926,660
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2012-12-31$868,300
Value of total corrective distributions2012-12-31$39,446
Total contributions o plan (from employers,participants, others, non cash contrinutions)2012-12-31$748,062
Value of total assets at end of year2012-12-31$6,069,120
Value of total assets at beginning of year2012-12-31$4,932,164
Total of administrative expenses incurred including professional, contract, advisory and management fees2012-12-31$18,914
Total interest from all sources2012-12-31$14,038
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2012-12-31No
Was this plan covered by a fidelity bond2012-12-31Yes
Value of fidelity bond cover2012-12-31$500,000
If this is an individual account plan, was there a blackout period2012-12-31Yes
Were there any nonexempt tranactions with any party-in-interest2012-12-31No
Contributions received from participants2012-12-31$554,203
Participant contributions at end of year2012-12-31$163,857
Participant contributions at beginning of year2012-12-31$133,602
Participant contributions at end of year2012-12-31$1,815
Participant contributions at beginning of year2012-12-31$5,958
Income. Received or receivable in cash from other sources (including rollovers)2012-12-31$127,607
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2012-12-31$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2012-12-31$9,529
Total non interest bearing cash at beginning of year2012-12-31$15,652
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Value of net income/loss2012-12-31$331,144
Value of net assets at end of year (total assets less liabilities)2012-12-31$6,069,120
Value of net assets at beginning of year (total assets less liabilities)2012-12-31$4,922,635
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2012-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2012-12-31No
Were any leases to which the plan was party in default or uncollectible2012-12-31No
Investment advisory and management fees2012-12-31$18,914
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2012-12-31$0
Value of interest in pooled separate accounts at end of year2012-12-31$5,034,294
Value of interest in pooled separate accounts at beginning of year2012-12-31$4,758,646
Interest on participant loans2012-12-31$6,070
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2012-12-31$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2012-12-31$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2012-12-31$7,968
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2012-12-31$869,154
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2012-12-31$16,120
Net investment gain/loss from registered investment companies (e.g. mutual funds)2012-12-31$41,032
Net investment gain/loss from pooled separate accounts2012-12-31$454,672
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2012-12-31No
Was there a failure to transmit to the plan any participant contributions2012-12-31No
Has the plan failed to provide any benefit when due under the plan2012-12-31No
Contributions received in cash from employer2012-12-31$66,252
Employer contributions (assets) at beginning of year2012-12-31$2,186
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2012-12-31$868,300
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32012-12-31Yes
Assets. Corporate common stocks other than exployer securities at beginning of year2012-12-31$0
Did the plan have assets held for investment2012-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2012-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2012-12-31Yes
Opinion of an independent qualified public accountant for this plan2012-12-31Disclaimer
Accountancy firm name2012-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2012-12-31542088418
2011 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2011 401k financial data
Total transfer of assets to this plan2011-12-31$2,072,764
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$9,529
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$9,529
Total income from all sources (including contributions)2011-12-31$252,298
Total of all expenses incurred2011-12-31$430,359
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2011-12-31$400,627
Expenses. Certain deemed distributions of participant loans2011-12-31$0
Value of total corrective distributions2011-12-31$12,418
Total contributions o plan (from employers,participants, others, non cash contrinutions)2011-12-31$330,406
Value of total assets at end of year2011-12-31$4,932,164
Value of total assets at beginning of year2011-12-31$3,037,461
Total of administrative expenses incurred including professional, contract, advisory and management fees2011-12-31$17,314
Total interest from all sources2011-12-31$1,901
Total dividends received (eg from common stock, registered investment company shares)2011-12-31$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2011-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2011-12-31$0
Was this plan covered by a fidelity bond2011-12-31Yes
Value of fidelity bond cover2011-12-31$500,000
If this is an individual account plan, was there a blackout period2011-12-31No
Were there any nonexempt tranactions with any party-in-interest2011-12-31No
Contributions received from participants2011-12-31$330,406
Participant contributions at end of year2011-12-31$133,602
Participant contributions at beginning of year2011-12-31$39,434
Participant contributions at end of year2011-12-31$5,958
Participant contributions at beginning of year2011-12-31$5,958
Income. Received or receivable in cash from other sources (including rollovers)2011-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at end of year2011-12-31$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2011-12-31$9,529
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2011-12-31$9,529
Total non interest bearing cash at end of year2011-12-31$15,652
Total non interest bearing cash at beginning of year2011-12-31$19,835
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Value of net income/loss2011-12-31$-178,061
Value of net assets at end of year (total assets less liabilities)2011-12-31$4,922,635
Value of net assets at beginning of year (total assets less liabilities)2011-12-31$3,027,932
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2011-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2011-12-31No
Were any leases to which the plan was party in default or uncollectible2011-12-31No
Investment advisory and management fees2011-12-31$7,683
Value of interest in registered invesment companies (eg mutual funds) at end of year2011-12-31$0
Value of interest in pooled separate accounts at end of year2011-12-31$4,758,646
Value of interest in pooled separate accounts at beginning of year2011-12-31$2,956,406
Interest on participant loans2011-12-31$1,441
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2011-12-31$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2011-12-31$460
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2011-12-31$16,120
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2011-12-31$13,642
Expenses. Payments to insurance carriers foe the provision of benefits2011-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2011-12-31$0
Net investment gain/loss from pooled separate accounts2011-12-31$-80,009
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2011-12-31No
Was there a failure to transmit to the plan any participant contributions2011-12-31Yes
Has the plan failed to provide any benefit when due under the plan2011-12-31No
Contributions received in cash from employer2011-12-31$0
Employer contributions (assets) at end of year2011-12-31$2,186
Employer contributions (assets) at beginning of year2011-12-31$2,186
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2011-12-31$400,627
Contract administrator fees2011-12-31$9,631
Assets. Corporate common stocks other than exployer securities at end of year2011-12-31$0
Did the plan have assets held for investment2011-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2011-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2011-12-31Yes
Opinion of an independent qualified public accountant for this plan2011-12-31Disclaimer
Accountancy firm name2011-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2011-12-31542088418
2010 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2010 401k financial data
Total transfer of assets to this plan2010-12-31$399,394
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$9,529
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$50,978
Total income from all sources (including contributions)2010-12-31$709,128
Total of all expenses incurred2010-12-31$194,706
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2010-12-31$194,706
Total contributions o plan (from employers,participants, others, non cash contrinutions)2010-12-31$369,383
Value of total assets at end of year2010-12-31$3,009,482
Value of total assets at beginning of year2010-12-31$2,146,644
Total interest from all sources2010-12-31$3,300
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2010-12-31No
Was this plan covered by a fidelity bond2010-12-31Yes
Value of fidelity bond cover2010-12-31$500,000
If this is an individual account plan, was there a blackout period2010-12-31No
Were there any nonexempt tranactions with any party-in-interest2010-12-31No
Contributions received from participants2010-12-31$349,760
Participant contributions at end of year2010-12-31$39,434
Participant contributions at beginning of year2010-12-31$21,813
Participant contributions at end of year2010-12-31$5,958
Participant contributions at beginning of year2010-12-31$4,907
Income. Received or receivable in cash from other sources (including rollovers)2010-12-31$19,623
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2010-12-31$9,529
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2010-12-31$50,978
Total non interest bearing cash at end of year2010-12-31$19,835
Total non interest bearing cash at beginning of year2010-12-31$19,540
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Value of net income/loss2010-12-31$514,422
Value of net assets at end of year (total assets less liabilities)2010-12-31$3,009,482
Value of net assets at beginning of year (total assets less liabilities)2010-12-31$2,095,666
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2010-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2010-12-31No
Were any leases to which the plan was party in default or uncollectible2010-12-31No
Value of interest in pooled separate accounts at end of year2010-12-31$2,956,406
Value of interest in pooled separate accounts at beginning of year2010-12-31$2,101,657
Interest on participant loans2010-12-31$1,254
Interest earned on other investments2010-12-31$2,046
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2010-12-31$13,642
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2010-12-31$11,185
Net investment gain/loss from pooled separate accounts2010-12-31$336,445
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2010-12-31No
Was there a failure to transmit to the plan any participant contributions2010-12-31No
Has the plan failed to provide any benefit when due under the plan2010-12-31No
Employer contributions (assets) at end of year2010-12-31$2,186
Employer contributions (assets) at beginning of year2010-12-31$7,082
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2010-12-31$194,706
Did the plan have assets held for investment2010-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2010-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2010-12-31Yes
Opinion of an independent qualified public accountant for this plan2010-12-31Disclaimer
Accountancy firm name2010-12-31VISSE & COMPANY
Accountancy firm EIN2010-12-31542088418
2009 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2009 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2009-12-31$9,112
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2009-12-31$9,411
Total income from all sources (including contributions)2009-12-31$789,008
Total of all expenses incurred2009-12-31$249,543
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2009-12-31$249,543
Total contributions o plan (from employers,participants, others, non cash contrinutions)2009-12-31$296,648
Value of total assets at end of year2009-12-31$2,141,656
Value of total assets at beginning of year2009-12-31$1,602,490
Total interest from all sources2009-12-31$2,706
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2009-12-31No
Was this plan covered by a fidelity bond2009-12-31Yes
Value of fidelity bond cover2009-12-31$500,000
If this is an individual account plan, was there a blackout period2009-12-31No
Were there any nonexempt tranactions with any party-in-interest2009-12-31No
Contributions received from participants2009-12-31$266,214
Participant contributions at end of year2009-12-31$21,813
Participant contributions at beginning of year2009-12-31$61,467
Participant contributions at end of year2009-12-31$4,641
Participant contributions at beginning of year2009-12-31$4,641
Income. Received or receivable in cash from other sources (including rollovers)2009-12-31$30,434
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2009-12-31$9,112
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2009-12-31$9,411
Total non interest bearing cash at end of year2009-12-31$19,540
Total non interest bearing cash at beginning of year2009-12-31$19,839
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2009-12-31No
Value of net income/loss2009-12-31$539,465
Value of net assets at end of year (total assets less liabilities)2009-12-31$2,132,544
Value of net assets at beginning of year (total assets less liabilities)2009-12-31$1,593,079
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2009-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2009-12-31No
Were any leases to which the plan was party in default or uncollectible2009-12-31No
Value of interest in pooled separate accounts at end of year2009-12-31$2,082,291
Value of interest in pooled separate accounts at beginning of year2009-12-31$1,504,223
Interest on participant loans2009-12-31$2,332
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2009-12-31$374
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2009-12-31$11,185
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2009-12-31$10,134
Net investment gain/loss from pooled separate accounts2009-12-31$489,654
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2009-12-31No
Was there a failure to transmit to the plan any participant contributions2009-12-31Yes
Has the plan failed to provide any benefit when due under the plan2009-12-31No
Employer contributions (assets) at end of year2009-12-31$2,186
Employer contributions (assets) at beginning of year2009-12-31$2,186
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2009-12-31$249,543
Did the plan have assets held for investment2009-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2009-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2009-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2009-12-31Yes
Opinion of an independent qualified public accountant for this plan2009-12-31Disclaimer
Accountancy firm name2009-12-31VISSE & COMPANY, CPAS
Accountancy firm EIN2009-12-31542088418
2008 : MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2008 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2008-12-31$9,411
Total income from all sources (including contributions)2008-12-31$-302,972
Total of all expenses incurred2008-12-31$460,447
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2008-12-31$460,447
Total contributions o plan (from employers,participants, others, non cash contrinutions)2008-12-31$447,235
Value of total assets at end of year2008-12-31$1,602,490
Value of total assets at beginning of year2008-12-31$2,356,498
Total interest from all sources2008-12-31$4,651
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2008-12-31No
Was this plan covered by a fidelity bond2008-12-31Yes
Value of fidelity bond cover2008-12-31$500,000
If this is an individual account plan, was there a blackout period2008-12-31No
Were there any nonexempt tranactions with any party-in-interest2008-12-31No
Contributions received from participants2008-12-31$319,422
Participant contributions at end of year2008-12-31$61,467
Participant contributions at beginning of year2008-12-31$60,512
Participant contributions at end of year2008-12-31$4,641
Participant contributions at beginning of year2008-12-31$9,200
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2008-12-31$9,411
Total non interest bearing cash at end of year2008-12-31$19,839
Total non interest bearing cash at beginning of year2008-12-31$4,522
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2008-12-31No
Value of net income/loss2008-12-31$-763,419
Value of net assets at end of year (total assets less liabilities)2008-12-31$1,593,079
Value of net assets at beginning of year (total assets less liabilities)2008-12-31$2,356,498
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2008-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2008-12-31No
Were any leases to which the plan was party in default or uncollectible2008-12-31No
Value of interest in pooled separate accounts at end of year2008-12-31$1,504,223
Value of interest in pooled separate accounts at beginning of year2008-12-31$2,273,239
Interest on participant loans2008-12-31$4,278
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2008-12-31$373
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2008-12-31$10,134
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2008-12-31$8,060
Net investment gain/loss from pooled separate accounts2008-12-31$-754,858
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2008-12-31No
Was there a failure to transmit to the plan any participant contributions2008-12-31Yes
Has the plan failed to provide any benefit when due under the plan2008-12-31No
Contributions received in cash from employer2008-12-31$127,813
Employer contributions (assets) at end of year2008-12-31$2,186
Employer contributions (assets) at beginning of year2008-12-31$965
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2008-12-31$460,447
Did the plan have assets held for investment2008-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2008-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2008-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2008-12-31Yes
Opinion of an independent qualified public accountant for this plan2008-12-31Disclaimer
Accountancy firm name2008-12-31VISSE & CO., CPAS
Accountancy firm EIN2008-12-31542088418

Form 5500 Responses for MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN

2022: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2022 form 5500 responses
2022-01-01Type of plan entitySingle employer plan
2022-01-01Plan funding arrangement – InsuranceYes
2022-01-01Plan funding arrangement – TrustYes
2022-01-01Plan benefit arrangement – InsuranceYes
2022-01-01Plan benefit arrangement - TrustYes
2021: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01Submission has been amendedYes
2021-01-01Plan funding arrangement – InsuranceYes
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement – InsuranceYes
2021-01-01Plan benefit arrangement - TrustYes
2020: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2020 form 5500 responses
2020-01-01Type of plan entitySingle employer plan
2020-01-01Plan funding arrangement – InsuranceYes
2020-01-01Plan funding arrangement – TrustYes
2020-01-01Plan benefit arrangement – InsuranceYes
2020-01-01Plan benefit arrangement - TrustYes
2019: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Plan funding arrangement – InsuranceYes
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement – InsuranceYes
2019-01-01Plan benefit arrangement - TrustYes
2018: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2018 form 5500 responses
2018-01-01Type of plan entitySingle employer plan
2018-01-01Plan funding arrangement – InsuranceYes
2018-01-01Plan funding arrangement – TrustYes
2018-01-01Plan benefit arrangement – InsuranceYes
2018-01-01Plan benefit arrangement - TrustYes
2017: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2017 form 5500 responses
2017-01-01Type of plan entitySingle employer plan
2017-01-01Plan funding arrangement – InsuranceYes
2017-01-01Plan funding arrangement – TrustYes
2017-01-01Plan benefit arrangement – InsuranceYes
2017-01-01Plan benefit arrangement - TrustYes
2016: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2016 form 5500 responses
2016-01-01Type of plan entitySingle employer plan
2016-01-01Plan funding arrangement – InsuranceYes
2016-01-01Plan funding arrangement – TrustYes
2016-01-01Plan benefit arrangement – InsuranceYes
2016-01-01Plan benefit arrangement - TrustYes
2015: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2015 form 5500 responses
2015-01-01Type of plan entitySingle employer plan
2015-01-01Plan funding arrangement – InsuranceYes
2015-01-01Plan funding arrangement – TrustYes
2015-01-01Plan benefit arrangement – InsuranceYes
2015-01-01Plan benefit arrangement - TrustYes
2014: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2014 form 5500 responses
2014-01-01Type of plan entitySingle employer plan
2014-01-01Plan funding arrangement – InsuranceYes
2014-01-01Plan funding arrangement – TrustYes
2014-01-01Plan benefit arrangement – InsuranceYes
2014-01-01Plan benefit arrangement - TrustYes
2013: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2013 form 5500 responses
2013-01-01Type of plan entitySingle employer plan
2013-01-01Plan funding arrangement – InsuranceYes
2013-01-01Plan funding arrangement – TrustYes
2013-01-01Plan benefit arrangement – InsuranceYes
2013-01-01Plan benefit arrangement - TrustYes
2012: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2012 form 5500 responses
2012-01-01Type of plan entitySingle employer plan
2012-01-01Plan funding arrangement – InsuranceYes
2012-01-01Plan funding arrangement – TrustYes
2012-01-01Plan benefit arrangement – InsuranceYes
2012-01-01Plan benefit arrangement - TrustYes
2011: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Plan funding arrangement – InsuranceYes
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement – InsuranceYes
2011-01-01Plan benefit arrangement - TrustYes
2009: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01Submission has been amendedNo
2009-01-01This submission is the final filingNo
2009-01-01This return/report is a short plan year return/report (less than 12 months)No
2009-01-01Plan is a collectively bargained planNo
2009-01-01Plan funding arrangement – InsuranceYes
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement – InsuranceYes
2009-01-01Plan benefit arrangement - TrustYes
2008: MOLECULAR EPIDEMIOLOGY INC 401K PROFIT SHARING PLAN 2008 form 5500 responses
2008-01-01Type of plan entitySingle employer plan
2008-01-01Submission has been amendedYes
2008-01-01Plan funding arrangement – InsuranceYes
2008-01-01Plan funding arrangement – TrustYes
2008-01-01Plan benefit arrangement – InsuranceYes
2008-01-01Plan benefit arrangement - TrustYes

Insurance Providers Used on plan

TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )
Policy contract number513768-000
Policy instance 1
Insurance contract or identification number513768-000
Total amount of commissions paid to insurance brokerUSD $10,945
Total amount of fees paid to insurance companyUSD $10,945
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Commission paid to Insurance BrokerUSD $10,945
Insurance broker organization code?5
TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )
Policy contract number802884-000
Policy instance 1
Insurance contract or identification number802884-000
Total amount of commissions paid to insurance brokerUSD $19,492
Total amount of fees paid to insurance companyUSD $3,331
Commission paid to Insurance BrokerUSD $19,492
Insurance broker organization code?3
Amount paid for insurance broker fees3331
TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )
Policy contract number513768-000
Policy instance 2
Insurance contract or identification number513768-000
Total amount of fees paid to insurance companyUSD $7,273
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Amount paid for insurance broker fees7273
Insurance broker organization code?5
TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )
Policy contract number802884-000
Policy instance 1
Insurance contract or identification number802884-000
Total amount of commissions paid to insurance brokerUSD $47,559
Total amount of fees paid to insurance companyUSD $7,973
Are there contracts with allocated funds for types other than group deferred annuity or individual?Yes
Other information about contractSTABLE VALUE OPTION
Commission paid to Insurance BrokerUSD $47,559
Insurance broker organization code?3
Amount paid for insurance broker fees7973
TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )
Policy contract number802884-000
Policy instance 1
Insurance contract or identification number802884-000
Total amount of commissions paid to insurance brokerUSD $40,655
Total amount of fees paid to insurance companyUSD $6,840
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Commission paid to Insurance BrokerUSD $40,655
Insurance broker organization code?3
Amount paid for insurance broker fees6840
TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )
Policy contract number802884-000
Policy instance 1
Insurance contract or identification number802884-000
Number of Individuals Covered300
Insurance policy start date2017-01-01
Insurance policy end date2017-12-31
Total amount of commissions paid to insurance brokerUSD $37,607
Total amount of fees paid to insurance companyUSD $5,391
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Commission paid to Insurance BrokerUSD $32,216
Insurance broker organization code?3
Insurance broker nameHUNNEX AND SHOEMAKER, INC

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S3